Skip to content

Research on the Central Mechanism of Acupuncture in Improving Insomnia during Perimenopause and Its Efficacy Prediction

Research on the Central Mechanism of Acupuncture in Improving Insomnia during Perimenopause and Its Efficacy Prediction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001179
Enrollment
Unknown
Registered
2026-05-07
Start date
2025-03-10
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Sponsors

Pidu District Hospital of Traditional Chinese Medicine, Chengdu City
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: Perimenopausal Insomnia Subjects: (1) Female, aged 40 to 60 years, right-handed; (2) Meet the diagnostic criteria of the 10th Edition of the Reproductive Aging Staging and the 3rd Edition of the International Classification of Sleep Disorders; (3) Pittsburgh Sleep Quality Index (PSQI) score > 7; (4) Had not taken any medication for at least 2 weeks before entering the study; (5) Voluntarily participated in this study and signed the informed consent form. Note: Only patients meeting all 5 of the above criteria can be included in this study. Healthy Subjects: (1) Female, aged 40 to 60 years, right-handed; (2) Meet the diagnostic criteria of the 10th Edition of STRAW+10; (3) Pittsburgh Sleep Quality Index (PSQI) score = 7; (4) Had not taken any medication for at least 2 weeks before entering the study; (5) Voluntarily participated in this study and signed the informed consent form. Note: Only patients meeting all 5 of the above criteria can be included in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with bilateral ovarian removal, organic ovarian diseases, premature ovarian failure, polycystic ovary syndrome, hypothalamic amenorrhea; (2) Patients with systemic diseases such as hypertension, diabetes, coronary heart disease, obesity (BMI = 28); (3) Patients with severe life-threatening primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system diseases; (4) Patients with unconsciousness and inability to express subjective discomfort symptoms; (5) Patients with a history of mental disorders or organic neurological lesions in themselves or their first-degree relatives; (6) Patients with insomnia caused by alcohol abuse and/or abuse of psychotropic drugs (including sleeping pills); (7) Patients with severe depression and anxiety symptoms; (8) Patients with severe headache, migraine, history of head trauma and surgical history; (9) Patients who received estrogen, serotonin reuptake inhibitors or other alternative therapies within 4 weeks before enrollment; (10) Patients with a history of anticoagulants or regular use of sedatives or anti-anxiety drugs; (11) Patients who are pregnant, planning to become pregnant or breastfeeding; (12) Patients with claustrophobia, implanted metallic objects in the body, metal braces, etc., who have contraindications for magnetic resonance scanning. Note: All subjects who meet any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;Insomnia severity index;

Secondary

MeasureTime frame
Self Rating Depression Scale;Self Rating Anxiety Scale;Montreal Cognitive Assessment;Changes in brain structure;Chang in brain function;Serum inflammatory markers;Changes in the gut microbiota;

Countries

China

Contacts

Public ContactXiaoQin Chen

Pidu District Hospital of Traditional Chinese Medicine, Chengdu City, Sichuan Province

522540125@qq.com13689011332

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026